Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 04 2023
Historique:
accepted: 22 12 2022
pmc-release: 01 04 2024
medline: 4 4 2023
pubmed: 16 3 2023
entrez: 15 3 2023
Statut: ppublish

Résumé

The objectives were to describe mortality and causes of death in children with intraventricular hemorrhage (IVH) and to study neurodevelopmental outcomes. The study was a secondary analysis of the French national prospective and population-based cohort EPIPAGE-2. Children were recruited in 2011. A standardized assessment was conducted at age 5. Children born before 32 weeks' gestation and admitted to a NICU were eligible. Exposure was IVH defined by the Papile classification. Main outcomes were mortality, causes of death, and neurodevelopmental outcomes at age 5. Among the 3468 children included, 578 (16.7%) had grade 1 IVH, 424 (12.2%) grade 2 IVH, and 114 (3.3%) grade 3 IVH; 144 (4.1%) had intraparenchymal hemorrhage (IPH). Mortality was 29.7% (36 of 114) for children with grade 3 IVH and 74.4% (109 of 144) for those with IPH; 67.6% (21 of 31) and 88.7% (86 of 97) of deaths, respectively, were because of withholding and withdrawing of life-sustaining treatment. As compared with no IVH, low-grade IVH was not associated with measured neurodevelopmental disabilities at age 5. High-grade IVH was associated with moderate and severe neurodevelopmental disabilities, reduced full-scale IQ, and cerebral palsy. Rates of neurodevelopmental disabilities at age 5 did not differ between children without IVH and those with low-grade IVH. For high-grade IVH, mortality rate was high, mostly because of withholding and withdrawal of life-sustaining treatment, and we found a strong association with overall neurodevelopmental disabilities in survivors.

Identifiants

pubmed: 36919442
pii: 190840
doi: 10.1542/peds.2022-059138
pmc: PMC10071431
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 by the American Academy of Pediatrics.

Références

Childs Nerv Syst. 2012 Dec;28(12):2085-92
pubmed: 22914924
J Perinatol. 2017 Apr;37(4):441-447
pubmed: 27977011
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Pediatrics. 2016 Jul;138(1):
pubmed: 27354457
BMJ. 2017 Aug 16;358:j3448
pubmed: 28814566
BMJ. 2021 Apr 28;373:n741
pubmed: 33910920
J Perinatol. 2015 Jul;35(7):511-5
pubmed: 25654365
Arch Dis Child Fetal Neonatal Ed. 2022 Sep;107(5):513-519
pubmed: 34930831
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Pediatrics. 2014 Jan;133(1):55-62
pubmed: 24379238
Arch Dis Child Fetal Neonatal Ed. 2017 Mar;102(2):F96-F97
pubmed: 27974340
Semin Fetal Neonatal Med. 2022 Feb;27(1):101224
pubmed: 33888444
BMC Pediatr. 2014 Apr 09;14:97
pubmed: 24716860
PLoS One. 2019 Apr 4;14(4):e0214232
pubmed: 30946750
JAMA Pediatr. 2015 Mar;169(3):230-8
pubmed: 25621457
Arch Dis Child Fetal Neonatal Ed. 2021 Jan;106(1):4-8
pubmed: 32732377
Int J Epidemiol. 2020 Apr 1;49(2):368-369j
pubmed: 31747017
Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F102-7
pubmed: 26253166
Pediatrics. 2015 Dec;136(6):1132-43
pubmed: 26598455
Neonatology. 2017;112(3):203-210
pubmed: 28704824
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
J Pediatr. 2020 Nov;226:36-44.e3
pubmed: 32739261
JAMA Pediatr. 2013 May;167(5):451-9
pubmed: 23460139
BMC Med Res Methodol. 2021 Jun 6;21(1):118
pubmed: 34092226
BMC Pediatr. 2018 Aug 31;18(1):288
pubmed: 30170570

Auteurs

Ludovic Tréluyer (L)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.
Department of Neonatal Medicine of Port Royal, Cochin Hospital, FHU PREMA, AP-HP Centre - Université Paris Cité, Paris, France.

Marie Chevallier (M)

NICU, Grenoble Alps University Hospital Centre Couples and Children Section, Grenoble, France.
TIMC-IMAG Research Department, Grenoble Alps University, Grenoble, France.

Pierre-Henri Jarreau (PH)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.
Department of Neonatal Medicine of Port Royal, Cochin Hospital, FHU PREMA, AP-HP Centre - Université Paris Cité, Paris, France.

Olivier Baud (O)

Division of Neonatology and Pediatric Intensive Care, Children's University Hospital of Geneva, Geneva, Switzerland.
Université Paris Cité, Inserm U1141, Paris, France.

Valérie Benhammou (V)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.

Catherine Gire (C)

Department of Neonatology, North Hospital, University Hospital of Marseille,Chemin des Bourrelys, CEDEX 20, Marseille, France.

Laetitia Marchand-Martin (L)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.

Stéphane Marret (S)

Department of Neonatal Pediatrics, Intensive Care, and Neuropediatrics, Rouen University Hospital, Rouen, France and INSERM Unit 1245, Team Perinatal Handicap, School of Medicine of Rouen, Normandy University, Normandy, France.

Véronique Pierrat (V)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.
Department of Neonatal Medicine, CHU Lille, Jeanne de Flandre Hospital, Lille, France.

Pierre-Yves Ancel (PY)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.
Clinical Research Unit, Center for Clinical Investigation P1419, Assistance Publique-Hôpitaux de Paris, Paris, France.

Héloïse Torchin (H)

CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France.
Department of Neonatal Medicine of Port Royal, Cochin Hospital, FHU PREMA, AP-HP Centre - Université Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH